Connect with us

Awareness

New study: Vaccine Manufacturers & FDA Regulators Caught Hiding Risks of HPV Vaccines

Published

on

New Documentary: Watch: The Truth about vaccines – bit.ly/2uKN1FO

advertisement - learn more

A new study published in Clinical Rheumatology exposes how vaccine manufacturers used phony placebos in clinical trials to conceal a wide range of devastating risks associated with HPV vaccines. Instead of using genuine inert placebos and comparing health impacts over a number of years, as is required for most new drug approvals, Merck and GlaxoSmithKline spiked their placebos with a neurotoxic aluminum adjuvant and cut observation periods to a matter of months.

--> Help Support CE: Become a member of CETV and get access to exclusive news and courses to help empower you to become an effective changemaker. Also, help us beat censorship! Click here to join.

Researchers from Mexico’s National Institute of Cardiology pored over 28 studies published through January 2017—16 randomized trials and 12 post-marketing case series—pertaining to the three human papillomavirus (HPV) vaccines currently on the market globally. In their July 2017 peer-reviewed report, the authors, Manuel Martínez-Lavin and Luis Amezcua-Guerra, uncovered evidence of numerous adverse events, including life-threatening injuries, permanent disabilities, hospitalizations and deaths, reported after vaccination with GlaxoSmithKline’s bivalent Cervarix vaccine and Merck’s quadrivalent or nine-valent HPV vaccines (Gardasil and Gardasil 9). Pharmaceutical company scientists routinely dismissed, minimized or concealed those injuries using statistical gimmicks and invalid comparisonsdesigned to diminish their relative significance.

Of the 16 HPV vaccine randomized trials, only two used an inert saline placebo. Ten of the sixteen compared the HPV vaccine against a neurotoxicaluminum adjuvant, and four trials used an already-approved aluminum-containing vaccine as the comparison.

Scientific researchers view double-blind placebo trials as the gold standard for testing new drugs. To minimize bias, investigators randomly assign patients to either a “treatment” group or a “control” (placebo) group and then compare health outcomes. The standard practice is to compare a new drug against a “pharmacologically inert” placebo. To minimize opportunities for bias, neither patients nor researchers know which individuals received the drug and which the placebo. However, in clinical trials of the various HPV vaccines, pharmaceutical researchers avoided this kind of rigor and instead employed sleight-of-hand flimflams to mask the seriousness of vaccine injuries.

Of the 16 HPV vaccine randomized trials, only two used an inert saline placebo. Ten of the sixteen compared the HPV vaccine against a neurotoxic aluminum adjuvant, and four trials used an already-approved aluminum-containing vaccine as the comparison. One does not have to be a scientist to understand that using aluminum-containing placebos is likely to muddy the comparison between the treatment and control groups. Critics of the HPV vaccine have pointed to the aluminum adjuvant as the most likely cause of adverse reactions, and some researchers have questioned the safety of using aluminum adjuvants in vaccines at all, due to their probable role as a contributor to chronic illness. The aluminum-containing placebos appeared to provoke numerous adverse reactions among the presumably unwitting patients who received them, allowing the pharma researchers to mask the cascade of similar adverse reactions among the groups that received the vaccines. Although both placebo and study groups suffered numerous adverse events in these studies, there were minimal differences between the two groups. The similar adverse outcomes in both groups allowed industry researchers and government regulators to claim that the vaccines were perfectly safe, despite manifold disturbing reactions. The Mexican researchers’ meta-review confirms the difficulty of ascertaining vaccine-attributable differences from this mess; the researchers identified only a few indications of “significantly increased systemic adverse events in the HPV vaccine group vs. the control group” across the 16 pre-licensure trials.

The HPV promoters found it more difficult to employ deceptive devices in the 12 post-marketing safety reviews, and the Mexican authors summarize some of the more noteworthy findings. In Spain, they found a ten-fold higher incidence of vaccine-related adverse events following HPV vaccination compared to “other types of vaccines.” In Canada, they found an astonishing one in ten rate of hospital emergency department visits among HPV-vaccinated individuals “within 42 days after immunization.” Still, the industry researchers did what they could to minimize these injuries. The Mexican reviewers criticize the authors of the various post-marketing studies for failing to ask essential questions, to evaluate the many serious adverse events, or to elaborate on their often-troubling findings.

advertisement - learn more

Abbreviated Trial Times

Typically, FDA requires drug companies seeking approval for a new drug to observe health outcomes in both the placebo and study groups for 4-5 years. Vaccine manufacturers take advantage of FDA regulatory loopholes that allow fast-tracking of vaccines and cut that period down to a few weeks or even a few days. This means that injuries that manifest, or are diagnosed, later in life—most neurodevelopmental disorders, for example—will escape attention entirely.

Further Smokescreens

Martínez-Lavin and Amezcua-Guerra point to clinical trial data posted on the FDA webpagefor the quadrivalent Gardasil vaccine approved in 2006. Those clinical trials deployed a panoply of the kind of cunning deceptions used by industry and government researchers. Unlike many of the other HPV vaccine clinical trials, these clinical studies employed a true saline placebo.

Across the Gardasil clinical studies, a group of 15,706 females ages 9-45 and males ages 9-26 received the quadrivalent Gardasil vaccine. A control group of 594 individuals received an inert saline placebo. The industry researchers never explain the tiny relative size of the saline placebo group; it’s noteworthy that small size would have the effect of keeping unwanted signals weak. But a second control group of 13,023 received a so-called “spiked” placebo loaded with an aluminum adjuvant (amorphous aluminum hydroxyphosphate sulfate or AAHS). The large size of this “spiked placebo” group suggests that the decision to keep the saline placebo group small was strategic.

Putting aside the thorny ethical question of whether study participants were told that they were being injected with a neurotoxin with probable associations with Alzheimer’s, dementia and other forms of brain disease, the inclusion of both saline and aluminum placebos provided these researchers a chance to do some genuine science. But the FDA webpage shows the troubling gimmick that was then employed by the FDA and Merck, which seems deliberately designed to blur datasets in order to mask adverse effects during the clinical trials. The table showing relatively minor injection-site adverse reactions—one to five days post-vaccination—displays three distinct columns for the three groups: Gardasil recipients, the aluminum “placebo” recipients, and saline placebo recipients (see table below). In the table, “Intergroup differences are obvious,” in the words of the Mexican researchers. For example, roughly three and a half times more girls/women experienced injection site swelling in the Gardasil group compared to the saline group (25.4% vs. 7.3%). In fact, by all five measures, both the Gardasil recipients and the aluminum placebo recipients fared two to three times worse than the saline recipients.

When it came time for Merck to report on the occurrence of more serious reactions, “Systemic Adverse Reactions” and “Systemic Autoimmune Disorders,” for example, the company scientists switched to a very different format. In these tables, the third column that reported results for the saline placebo recipients disappears. Instead, Merck combined the groups receiving the spiked aluminum placebo into a single column with the group receiving the genuine saline placebo (see example below). The merger of the two control groups makes it impossible to compare results for Gardasil versus the saline placebo or the aluminum placebo versus the saline placebo. In this way, Merck’s researchers obliterated any hope of creating a meaningful safety comparison.

Risks and Benefits

Given aluminum’s known neurotoxicity and its association with debilitating autoimmune conditions, it is unsurprising that there are no observable differences between the Gardasil and AAHS/saline groups. But, despite the researchers’ efforts to paper over adverse effects, they were not able to conceal the devastating health injuries to their human guinea pigs. The bottom line of these trials reveals a shocking truth: An alarming 2.3% of both their study and control groups had indicators of autoimmune diseases! These data are even more alarming when one considers that the observation period was curtailed after only six months. With this level of risk, it would seem that no loving parents would allow their daughter to receive this vaccine—particularly given the comparatively low risk posed by HPV in countries with appropriate cervical cancer screening tests. Even in countries such as India, where cervical cancer mortality is high due to late detection, leading Indian physicians argue that comprehensive screening should be the country’s top priority rather than the “panacea” of HPV vaccination.

Consider the math: According to the National Institutes of Health (NIH), an estimated 2.4 women per 100,000 die of cervical cancer in the US each year. On the other hand, the FDA’s Table 2 (above) shows that 2.3 per 100 girls and women developed an “incident condition potentially indicative of a systemic autoimmune disorder” after enrolling in the Gardasil clinical trial. It is difficult to understand how any rational regulator could allow more than two in 100 girls to run the risk of acquiring a lifelong autoimmune disorder, particularly when Pap smears are already doing an effective job of identifying cervical abnormalities. The NIH notes that the incidence and death rates for cervical cancer in the US declined by more than 60% after introducing Pap smear screening.

Based on the numerical outcomes of that study, the Mexican researchers calculated the likelihood of being actually “helped or harmed by the 9-valent HPV vaccine.” Their “worrisome” finding is that the “number needed to harm” is just 140, whereas 1757 women would need to receive the vaccine for a single one of them to enjoy its projected benefits.

Martínez-Lavin and Amezcua-Guerra make their own effort to illustrate the zany risk-benefit ratios associated with these vaccines when discussing the results of one of the 16 clinical trials. That study compared approximately 14,000 women who received either Gardasil 9 or the original quadrivalent Gardasil. Based on the numerical outcomes of that study, the Mexican researchers calculated the likelihood of being actually “helped or harmed by the 9-valent HPV vaccine.” Their “worrisome” finding is that the “number needed to harm” is just 140, whereas 1757 women would need to receive the vaccine for a single one of them to enjoy its projected benefits.

Implications for Aluminum Adjuvants

Merck found that astronomical casualty counts were equal among both Gardasil and aluminum “placebo” recipients. The inescapable implication is that aluminum adjuvants may be a principal culprit in the flood of injuries reported for the various HPV vaccines. This conclusion, if true, requires reevaluation of the use of aluminum adjuvants in several other vaccines, including some given to infants. Aluminum adjuvant levels have mushroomed since the 2003 removal of thimerosal from three pediatric vaccines. The following chart, prepared by Dr. Sherri Tenpenny, illustrates the stunning amount of aluminum in vaccines.

Multiple peer-reviewed studies have connected aluminum exposures to a range of autoimmune and neurological disorders, including dementia and Alzheimer’s disease, that have become epidemic coterminous with these aluminum exposures. A review in the European Journal of Clinical Nutrition warns of dangerous accumulation of aluminum in the brain when, as in the case of vaccination, “protective gastrointestinal mechanisms are bypassed.” It’s time to go back to the drawing board on HPV vaccines and aluminum adjuvants. More importantly, FDA needs to start requiring the same rigorous pre-licensing safety testing for vaccines that it has long required for other drugs. All existing vaccines, particularly those containing aluminum, should be safety-reviewed according to these more stringent standards.

Sign up for free news and updates from Robert F. Kennedy, Jr. and the World Mercury Project. Your donation will help to support us in our efforts.

Become Part of CE's Inner Circle

Collective Evolution is one of the world's fastest-growing conscious media and education companies providing news and tools to raise collective consciousness. Get inside access to Collective Evolution by becoming a member of CETV.

Stream content 24/7 and enjoy mind-expanding interviews, original shows, documentaries and guided programs.

Click here to start a FREE 7-Day Trial and help conscious media thrive!

Advertisement
advertisement - learn more

Alternative News

CDC Director: ‘Masks May Offer More Protection From COVID-19 Than The Vaccine’

Published

on

In Brief

  • The Facts:

    CDC director Robert Redfield said on Wednesday that wearing a mask might be "more guaranteed" to protect an individual from the coronavirus than a vaccine.

  • Reflect On:

    Why is there so much conflicting information out there? Why is it so difficult to arrive at any concrete truth? How does the politicization of science play a role?

What Happened: Centers For Disease Control (CDC) Director Robert Redfield recently stated that wearing a mask may be “more guaranteed” to protect an individual from the coronavirus than a vaccine. This calls into question the efficacy of the vaccine, which is set to make its way into the public domain at the end of this year, or shortly after that. We thought we’d cover this story to bring up the efficacy of vaccines in general, and the growing vaccine hesitancy that now exists within a number of people, scientists and physicians across the world.

“I’m not gonna comment directly about the president, but I am going to comment as the CDC director that face masks, these face masks, are the most important powerful public health tool we have.” – Redfield

Not long ago, many scientists presented facts about vaccines and vaccine safety at the recent Global Health Vaccine Safety summit hosted by the World Health Organization in Geneva, Switzerland. At the conference, Professor Heidi Larson, a Professor of Anthropology and the Risk and Decision Scientist Director at the Vaccine Confidence Project emphasized the issue of growing vaccine hesitancy.

The other thing that’s a trend, and an issue, is not just confidence in providers but confidence of health care providers, we have a very wobbly health professional frontline that is starting to question vaccines and the safety of vaccines. That’s a huge problem, because to this day any study I’ve seen… still, the most trusted person on any study I’ve seen globally is the health care provider…”

Redfield’s comments came after President Trump downplayed the effectiveness of wearing mask, and Trump also stated that Covid would probably go away without a vaccine, referring to the concept of ‘herd immunity’ as practiced in Sweden, but has also been quite outspoken about the fact that a vaccine may arrive by November.

When it comes to the COVID vaccine, multiple clinical trials for COVID-19 vaccines have shown severe reactions within 10 days after taking the vaccine. You can read more about that here.  The US government and Yale University also recently collaborated in a clinical trial to determine the best messaging to persuade Americans to take the COVID-19 vaccine. You can read more about that here.

Are Masks Effective?

Multiple studies have claimed to show definitively  that mask-wearing effectively prevents transmission of the coronavirus, especially recent ones. This seems to be the general consensus and the information that’s come from our federal health regulatory agencies. There are also multiple studies calling the efficacy of masks into question. For example, a fairly recent study published in the New England Medical Journal  by a group of Harvard doctors outlines how it’s already known that masks provide little to zero benefit when it comes to protection a public setting. According to them,

We know that wearing a mask outside health care facilities offers little, if any, protection from infection. Public health authorities define a significant exposure to Covid-19 as face-to-face contact within 6 feet with a patient with symptomatic Covid-19 that is sustained for at least a few minutes (and some say more than 10 minutes or even 30 minutes). The chance of catching Covid-19 from a passing interaction in a public space is therefore minimal. In many cases, the desire for widespread masking is a reflexive reaction to anxiety over the pandemic.

You can read more about that story here and find other complimenting studies.

When it comes to masks, there are multiple studies on both sides of the coin.

Then we have many experts around the world calling into question everything from masks to lockdown. For example, The Physicians For Informed Consent (PIC) recently published a report titled “Physicians for Informed Consent (PIC) Compares COVID-19 to Previous Seasonal and Pandemic Flu Periods.” According to them, the infection/fatality rate of COVID-19 is 0.26%.

They are one of many who have emphasized this point.

More than 500 German doctors & scientists have signed on as representatives of an organization called the “Corona Extra-Parliamentary Inquiry Committee” to investigate what’s happening on our planet with regards to COVID-19, and also make similar points. You can read more about that story here.

Again, there are many examples from all over the world from various academics, doctors and scientists in the field.

This is why there is so much confusion surrounding this pandemic, because there is so much conflicting information that opposes what we are hearing from our health authorities. Furthermore, a lot of information that opposes the official narrative has been censored from social media platforms, also raising suspicion among the general public.

How Effective Are Vaccines?

Vaccines have been long claimed to be a miracle, and the most important health intervention for the sake of disease prevention of our time. But as mentioned above, vaccine hesitancy is growing, and it’s growing fast.

According to a study published in the journal EbioMedicine,

Over the past two decades several vaccine controversies have emerged in various countries, including France, inducing worries about severe adverse effects and eroding confidence in health authorities, experts, and science. These two dimensions are at the core of the vaccine hesitancy (VH) observed in the general population. These two dimensions are at the core of the vaccine hesitancy (VH) observed in the general population. VH is defined as delay in acceptance of vaccination, or refusal, or even acceptance with doubts about its safety and benefits, with all these behaviors and attitudes varying according to context, vaccine, and personal profile, despite the availability of vaccine services. VH presents a challenge to physicians who must address their patients’ concerns about vaccines..

In the United States, the Vaccine Adverse Event Reporting System (VAERS) shows what vaccines have resulted in deaths, injury, permanent disabilities and hospitalizations. The National Childhood Vaccine Injury act has also paid out nearly $4 billion dollars to families of vaccine injured children.

According to a MedAlerts, the cumulative raw count of adverse events from measles, mumps, and rubella vaccines alone was: 93,929 adverse events, 1,810 disabilities, 6,902 hospitalizations, and 463 deaths. What is even more disturbing about these numbers is that VAERS is a voluntary and passive reporting system that has been found to only capture 1% of adverse events.

The measles vaccine has also been plagued with a lack of effectiveness, with constant measles outbreaks in heavily vaccinated population pointing towards a failing vaccine. You can read more about that in-depth and access more science on it here. In 2015, nearly 40 percent of measles cases analyzed in the US were a result of the vaccine.

It’s not just the MMR vaccine that shows a lack of effectiveness. For example, a new study published in The Royal Society of Medicine is one of multiple studies over the years that has emerged questioning the efficacy of the HPV vaccine. The researchers conducted an appraisal of published phase 2 and 3 efficacy trials in relation to the prevention of cervical cancer and their analysis showed “the trials themselves generated significant uncertainties undermining claims of efficacy” in the data they used. The researchers emphasized that “it is still uncertain whether human papillomavirus (HPV) vaccination prevents cervical cancer as trials were not designed to detect this outcome, which takes decades to develop.”  The researchers point out that the trials used to test the vaccine may have “overestimated” the efficacy of the vaccine.

It’s one of multiple studies to call into question the efficacy and safety of the HPV vaccine. It’s also been responsible for multiple deaths and permanent disabilities.

Another point to make regarding vaccine injury is that data was collected from June 2006 through October 2009 on 715,000 patients, and 1.4 million doses (of 45 different vaccines) were given to 376,452 individuals. Of these doses, 35,570 possible reactions (2.6 percent of vaccinations) were identified. This is an average of 890 possible events, an average of 1.3 events per clinician, per month. This data was presented at the 2009 AMIA conference. This data comes 2010 HHS pilot study by the Federal Agency for Health Care Research (AHCR) that found that 1 in every 39 vaccines causes injury, a shocking comparison to the claims from the CDC of 1 in every million. You can access that report and read more about it here.

The Takeaway: 

Become Part of CE's Inner Circle

Collective Evolution is one of the world's fastest-growing conscious media and education companies providing news and tools to raise collective consciousness. Get inside access to Collective Evolution by becoming a member of CETV.

Stream content 24/7 and enjoy mind-expanding interviews, original shows, documentaries and guided programs.

Click here to start a FREE 7-Day Trial and help conscious media thrive!

Continue Reading

Alternative News

1 Million + People Download Study Showing Heavy Aluminum Deposits In Autistic Brains

Published

on

In Brief

  • The Facts:

    A landmark paper published in 2018 showing high amounts of aluminum in autistic brains has not been dowloaded more than 1 million times.

  • Reflect On:

    Why are federal health regulatory agencies ignoring the emerging science showing concerns with regards to injected aluminum? Why don't they address the concerns and conduct safety studies?

What Happened: In 2018, Professor of Bioinorganic Chemistry at Keele University, who is considered one of the world’s leading experts in aluminum toxicology, published a paper in the Journal of Trace Elements in Medicine & Biology showing very high amounts of aluminum in the brain tissue of people with autism. Exley has examined more than 100 brains, and the aluminum content in these people is some of the highest he has ever seen and raises new questions about the role of aluminum in the etiology of autism. Five people were used in the study, comprising of four males and one female, all between the ages of 14-50. Each of their brains contained what the authors considered unsafe and high amounts of aluminum compared to brain tissues of patients with other diseases where high brain aluminum content is common, like Alzheimer’s disease, for example.

It’s now been downloaded by more than 1 million people. The photo below was posted recently via his Instagram account.

Here is a summary of the study’s main findings:

-All five individuals had at least one brain tissue with a “pathologically significant” level of aluminum, defined as greater than or equal to 3.00 micrograms per gram of dry brain weight (μg/g dry wt). (Dr. Exley and colleagues developed categories to classify aluminum-related pathology after conducting other brain studies, wherein older adults who died healthy had less than 1 μg/g dry wt of brain aluminum.)

-Roughly two-thirds (67%) of all the tissue samples displayed a pathologically significant aluminum content.

-Aluminum levels were particularly high in the male brains, including in a 15-year-old boy with ASD who had the study’s single highest brain aluminum measurement (22.11 μg/g dry wt)—many times higher than the pathologically significant threshold and far greater than levels that might be considered as acceptable even for an aged adult.

-Some of the elevated aluminum levels rivaled the very high levels historically reported in victims of dialysis encephalopathy syndrome (a serious iatrogenic disorder resulting from aluminum-containing dialysis solutions).

-In males, most aluminum deposits were inside cells (80/129), whereas aluminum deposits in females were primarily extracellular (15/21). The majority of intracellular aluminum was inside non-neuronal cells (microglia and astrocytes).

-Aluminum was present in both grey matter (88 deposits) and white matter (62 deposits). (The brain’s grey matter serves to process information, while the white matter provides connectivity.)

-The researchers also identified aluminum-loaded lymphocytes in the meninges (the layers of protective tissue that surround the brain and spinal cord) and in similar inflammatory cells in the vasculature, furnishing evidence of aluminum’s entry into the brain “via immune cells circulating in the blood and lymph” and perhaps explaining how youth with ASD came to acquire such shockingly high levels of brain aluminum.

Following up this paper, Exely recently published recently published a paper titled “The role of aluminum adjuvants in vaccines raises issues that deserve independent, rigorous and honest science.” In their publication, they provide evidence for their position that “the safety of aluminium-based vaccine adjuvants, like that of any environmental factor presenting a risk of neurotoxicity and to which the young child is exposed, must be seriously evaluated without further delay, particularly at a time when the CDC is announcing a still increasing prevalence of autism spectrum disorders, of 1 child in 54 in the USA.”

In the interview below, Exley answers a lot of questions, but the part that caught my attention was:

We have looked at what happens to the aluminum adjuvant when it’s injected and we have shown that certain types of cells come to the injection site and take up the aluminum inside them. You know, these same cells we also see in the brain tissue in autism. So, for the first time we have a link that honestly I had never expected to find between aluminum as an adjuvant in vaccines and that same aluminum potentially could be carried by those same cells across the blood brain barrier into the brain tissue where it could deposit the aluminum and produce a disease, Encephalopathy (brain damage), it could produce the more severe and disabling form of autism. This is a really shocking finding for us.

The interview is quite informative with regards to aluminum toxicology in general, but if you’re interested in the quote above, you can fast forward to the twelve minutes and thirty seconds mark.

Why This Is Important: There are many concerns being raised about aluminum in vaccines, and where that aluminum goes when it’s injected into the body. Multiple animal studies have now shown that when you inject aluminum, it doesn’t exit the body but travels to distant organs and eventually ends up in the brain where it’s detectable 1-10 years after injection. When we take in aluminum from our food or whatever however, the body does a great job of getting rid of it.

When you inject aluminum, it goes into a different compartment of your body. It doesn’t come into that same mechanism of excretion. So, and of course it can’t because that’s the whole idea of aluminum adjuvants, aluminum adjuvants are meant to stick around and allow that antigen to be presented over and over and over again persistently, otherwise you wouldn’t put an adjuvant in in the first place. It can’t be inert, because if it were inert it couldn’t do the things it does. It can’t be excreted because again it couldn’t provide that prolonged exposure of the antigen to your immune system. – Dr Christopher Shaw, University of British Columbia. (source)

Furthermore, federal health regulatory agencies have not appropriately studied the aluminum adjuvants mechanisms of action after injection, it’s simply been presumed safe after more than 90 years of use in various vaccines.

It’s also important to note that A group of scientists and physicians known as The Physicians For Informed Consent (PIC) have discovered a crucial math error in a FDA paper regarding the safety of aluminum in vaccines.

If you want to access the science and studies about injected aluminum not exiting the body, and more information about aluminum in vaccines in general, you can refer to THIS article, and THIS article I recently published on the subject that goes into more detail and provides more sources, science and exampels. 

The Takeaway: When it comes to vaccine safety, why does mainstream media constantly point fingers and call those who have concerns “anti-vax conspiracy theorists?” Why don’t they ever address the science and concerns being raised that paint vaccines in a light that they’ve never been painted in? What’s going on here? Would more rigorous safety testing of our vaccines not be in the best interests of everybody? Who would ever oppose that and why?

Become Part of CE's Inner Circle

Collective Evolution is one of the world's fastest-growing conscious media and education companies providing news and tools to raise collective consciousness. Get inside access to Collective Evolution by becoming a member of CETV.

Stream content 24/7 and enjoy mind-expanding interviews, original shows, documentaries and guided programs.

Click here to start a FREE 7-Day Trial and help conscious media thrive!

Continue Reading

Alternative News

CDC Virologist: OP Vaccine Has Created Polio Outbreaks

Published

on

In Brief

  • The Facts:

    According to Mark Pallansch, a CDC virologist, the oral polio vaccine has created more disease outbreaks than they've stopped. The oral polio vaccine is now responsible for many outbreaks across multiple countries.

  • Reflect On:

    Can these outbreaks caused by the oral polio vaccine really be brought under control by another vaccine used to combat the oral polio vaccine outbreaks? Is that such a good idea or is more caution warranted here?

This article has been updated and corrected. 

What Happened: In 2019 Mark Pallansch, a virologists with the U.S. Centers for Disease Control (CDC) in Atlanta, told sciencemag.org that by using mOPV2 (oral polio vaccine), “we have now created more new emergences of the virus than we have stopped.” This is known as “vaccine-derived poliovirus.” Yes, you read that correctly, and it’s one of multiple examples of vaccines causing disease outbreaks. For example, A study published in 2017 in the Journal of Clinical Microbiology found that “During the measles outbreak in California in 2015, a large number of suspected cases occurred in recent vaccinees. Of the 194 measles sequences obtained in the United States in 2015, 73 were identified as vaccine sequences…” This means 37 percent of the cases analyzed were a result of the vaccine. You can read more about the measles and the MMR vaccine specifically, here.

Why This Is Important: The spread of the virus due to the oral vaccine is plaguing Africa,

The global initiative to eradicate polio is badly stuck, battling the virus on two fronts. New figures show the wild polio virus remains entrenched in Afghanistan and in Pakistan, its other holdout, where cases are surging. In Africa, meanwhile, the vaccine itself is spawning virulent strains. The leaders of the world’s biggest public health program are now admitting that success is not just around the corner—and intensively debating how to break the impasse. (source)

Children’s Health Defense explains,

The oral polio vaccine (OPV) is in use around the world and constitutes the “workhorse” of global polio eradication efforts due to its low cost and ease of administration. The OPV contains live but weakened polioviruses that match up to wild polioviruses. Vaccine researchers have long known that these OPV-derived viruses can themselves cause polio, particularly when they get “loose in the environment.” In settings with poor sanitation and iffy hygiene, the vaccine viruses can easily “find their way into water sources, and onto contaminated hands or foods,” where they can then launch a self-perpetuating chain of transmission. Researchers concede that an OPV virus “can very rapidly regain its strength if it starts spreading on its own,” acquiring “mutations that make it basically indistinguishable from the wild-type virus.” In other words, there is no meaningful difference between a wild and OPV-derived poliovirus “in terms of virulence and in terms of how the virus spreads.”

The oral vaccine has been causing outbreaks in multiple countries for a long time, in fact,  it has been responsible for close to 90% of the vaccine-derived polioviruses circulating since the year 2000, but it was only recently when the World Health Organization (WHO) brought more attention to the issue via their website in September of this year.

In fact, between August 2019 and August 2020, there were 400 recorded cases of vaccine-derived polio in more than 20 countries worldwide

The Global Polio Eradication Initiative (GPEI), headed by the Bill & Melinda Gates foundation had scientists actually predict predict that some vaccine-virus-derived outbreaks would indeed occur, but they thought they could handle these outbreaks with another vaccine.

Now,

The frequency with which type 2 vaccine-derived outbreaks are occurring has far exceeded projections—and the rush to administer the new monovalent type 2 vaccine appears to be exacerbating rather than stemming the problem. In an astonishing admission, a CDC virologist has stated that due to the stop-gap use of the new type-2-only vaccine, “We have now created more new emergences of the virus than we have stopped.” Another vaccine expert has remarked, “if you just keep trickling in with a little bit of [monovalent] vaccine every time you think you have a problem all you’re doing is reseeding [more transmission chains].”

There had been no cases of wild poliovirus on the African continent since September 2016, but by July 2019, the WHO was cautioning that there was a high risk of ongoing type 2 vaccine virus spreading across Africa. Outbreak investigators have been documenting an uptick in circulating vaccine-derived  poliovirus type 2 in both human and environmental samples since mid-2017 (two years after the “switch”), generally obtaining human samples either from children presenting with acute flaccid paralysis (AFP) or from “healthy community contacts.” Although the WHO describes polio as just one of AFP’s possible causes, African labs have been isolating type 2 vaccine virus in case after case of AFP.

To date, surveillance reports have noted the presence of the vaccine-derived type 2 poliovirus in Angola, Cameroon, Central African Republic, the Democratic Republic of the Congo, Ethiopia, Ghana, Kenya, Mozambique, Niger, Nigeria, and Somalia. In Nigeria, type 2 has spread from the north of the country to Lagos—Nigeria’s largest and most densely populated city. In Ghana, soon after investigators found type 2 vaccine viruses in sewage in the capital of Accra, a toddler 400 miles away was diagnosed with vaccine virus paralysis—representing Ghana’s “first ever” reported outbreak of type 2 vaccine-derived poliovirus.

And to think in Pakistan they were jailing parents who were refusing to give their children the oral polio vaccine, perhaps they still are?

Something else to consider: According to fact-checker Health Feedback, “Vaccination has been effective in eradicating polio from the vast majority of developing countries, preventing an estimated 16 million cases and 1.5 million deaths worldwide. While vaccine-derived polio cases do occur, they are very rare and can be avoided by improving sanitation and vaccine coverage in vulnerable communities.”

They go on to state that

While vaccine-derived polio cases currently exceed wild poliovirus cases, this is only because polio vaccination campaigns have eradicated the wild virus from the vast majority of countries. Only one of the three original strains of wild poliovirus remains. In contrast to the estimated 350,000 children paralyzed by polio in 1988, which is the year when the GPEI launched the vaccination program, the WHO reported only 539 polio cases worldwide in 2019. In the absence of the oral vaccine, the virus could have paralyzed more than 6.5 million children in the past ten years.

You can read more about what they have to say, about polio and the polio vaccine here.

The Takeaway: Why is so much credible information about the safety concerns regarding vaccines never addressed by the mainstream media? Why do they never address and counter the concerns, and why instead do they constantly use ridicule and terms like “anti-vax conspiracy theorists?”  Would more rigorous safety testing of our vaccines not be in the best interests of everybody? Who would ever oppose that and why?

Related CE Article: Scientists Call For Safety Testing of Aluminum Based Vaccine Adjuvants

Become Part of CE's Inner Circle

Collective Evolution is one of the world's fastest-growing conscious media and education companies providing news and tools to raise collective consciousness. Get inside access to Collective Evolution by becoming a member of CETV.

Stream content 24/7 and enjoy mind-expanding interviews, original shows, documentaries and guided programs.

Click here to start a FREE 7-Day Trial and help conscious media thrive!

Continue Reading
advertisement - learn more
advertisement - learn more

Video

Due to censorship, please join us on Telegram

We post important content to Telegram daily so we don't have to rely on Facebook.

You have Successfully Subscribed!